2000
DOI: 10.1212/wnl.54.12.2237
|View full text |Cite
|
Sign up to set email alerts
|

Adjunctive therapy with oxcarbazepine in children with partial seizures

Abstract: OXC adjunctive therapy administered in a dose range of 6 to 51 mg/kg/day (median 31.4 mg/kg/day) is safe, effective, and well tolerated in children with partial seizures.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

5
133
2
3

Year Published

2003
2003
2020
2020

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 170 publications
(143 citation statements)
references
References 22 publications
5
133
2
3
Order By: Relevance
“…There is one study with class I evidence that evaluated the efficacy of oxcarbazepine in 267 children, aged 3 to 17 years, in a double-blind placebo controlled study. 72 The maximal doses of oxcarbazepine ranged between 30 and 46 mg/kg/day. A 50% responder rate of 41% was found among children on oxcarbazepine and 22% of children on placebo.…”
Section: Treatment Of Refractory Epilepsy In Children Question 4: Whmentioning
confidence: 99%
“…There is one study with class I evidence that evaluated the efficacy of oxcarbazepine in 267 children, aged 3 to 17 years, in a double-blind placebo controlled study. 72 The maximal doses of oxcarbazepine ranged between 30 and 46 mg/kg/day. A 50% responder rate of 41% was found among children on oxcarbazepine and 22% of children on placebo.…”
Section: Treatment Of Refractory Epilepsy In Children Question 4: Whmentioning
confidence: 99%
“…20 The study by Glauser included children between the ages of three and seventeen years with simple or complex crises of partial or generalized type, in accordance with the classification of the International League Against Epilepsy (1981 and 1989), which were not adequately controlled using one or two antiepileptic drugs concomitantly. 21 Patients who fulfilled the inclusion criteria were randomly distributed to receive oxcarbazepine 30 to 46 mg/kg or placebo. The outcomes analyzed were: incidence of seizure-free patients, dropout due to adverse events, incidence of adverse events and adverse events classified as serious.…”
Section: -18mentioning
confidence: 99%
“…The follow-up period was 112 days. 21 The study by Reinikainen included adult epilepsy patients with an unsatisfactory response to phenytoin or patients who had presented undesirable effects with this drug. The patients were randomized to receive oxcarbazepine 200 mg, increasing gradually to 800 mg; or carbamazepine 300 mg, increasing to 1,200 mg.…”
Section: -18mentioning
confidence: 99%
“…9,10 The practice of dedicating trials specifically to a given homogeneous population of patients represents a more rational strategy for the development of new antiepileptic drugs in children than testing such drugs on the whole population of refractory epilepsies. Controlled data can be obtained relatively rapidly on limited samples of patients, thus improving ethical acceptability of antiepileptic drug trials in a pediatric population.…”
Section: Efficacymentioning
confidence: 99%